Biotech's ATAI Life Sciences Joins Roster of Firms With Bitcoin Treasury Strategies

2 weeks ago

Another institution has elected to adhd bitcoin (BTC) to its equilibrium sheet.

Christian Angermayer, the president of Germany-based biopharmaceutical institution atai Life Sciences (ATAI) announced contiguous that the steadfast would make its ain bitcoin treasury strategy.

“In an epoch of persistent ostentation and volatile markets, I find myself asking an important question for biotech companies looking to sphere and optimize the superior they have: Could allocating a information of treasury currency to bitcoin assistance preserve, optimize, and adjacent widen a company’s runway and hence lend to its success,” Angermayer wrote connected Substack.

The institution volition initially put $5 cardinal successful bitcoin, Angermayer said, portion holding capable cash, short-term securities and nationalist equity for operational expenses into 2027.

The pharmaceutical steadfast is the latest successful a agelong enactment of corporations which person sought to replicate Michael Saylor’s bitcoin treasury strategy.

ATAI concisely surged erstwhile the quality broke but is present down 2.8% for the day. After concisely topping $87,000 overnight, bitcoin has been successful speedy retreat, present changing hands astatine $83,900, little by astir 1% implicit the past 24 hours.

View source